LEP and metabolic syndrome: Interestingly, TA patients have a greater prevalence of metabolic syndrome and higher levels of leptin and resistin, associated with upregulated inflammatory markers such as pentraxins-3 (Kawanami et al., 2004), compared to age-matched controls (Yilmaz et al., 2012; da Silva et al., 2013).